Ignite Creation Date:
2025-12-25 @ 3:44 AM
Ignite Modification Date:
2026-06-02 @ 2:08 PM
Study NCT ID:
NCT05429502
Status:
TERMINATED
Last Update Posted:
2025-10-10
First Post:
2022-06-17
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Efficacy and Safety of Ribociclib (LEE011) in Combination With Topotecan and Temozolomide (TOTEM) in Pediatric Patients With Relapsed or Refractory Neuroblastoma and Other Solid Tumors
Sponsor:
Novartis Pharmaceuticals
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Neuroblastoma | View |